# Scalability Plan

This document outlines how the BioSignal system can scale from a single prototype to a nationwide healthcare solution.

## 1. Hardware Scalability
- **Transition to Mass Production:** Moving from breadboard prototypes to automated PCB assembly (PCBA) lines.
- **Component Sourcing:** Selecting components that are widely available globally to avoid supply chain disruptions.

## 2. Software & AI Scalability
- **Federated Learning:** Instead of sending all patient data to a central server to improve the AI, the model can be updated locally on devices and only the model weights (not data) are shared with the server. This preserves privacy and scales efficiently.
- **Cloud Infrastructure:** While inference is on-device, the mobile app will use a secure cloud backend (e.g., AWS or Azure) to store anonymized alerts and sync data for doctors.

## 3. Clinical & Organizational Scalability
- **Telemedicine Integration:** The mobile app will have APIs to integrate with existing hospital information systems (HIS) using HL7 FHIR.
- **Training Programs:** Developing online training modules for nurses and doctors to learn how to interpret the BioSignal alerts.

## 4. Impact at Scale
If deployed nationally, BioSignal can:
- Reduce hospital readmissions for cardiac patients.
- Provide early warning signs for millions of high-risk patients, saving thousands of lives annually.
